Talk:Portmanteau inhibitor

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

AIDS Low‑importance

	This article is part of WikiProject AIDS, an attempt to build a comprehensive, detailed, and accessible guide to AIDS, HIV, and related topics on Wikipedia. If you would like to participate in the project, you can choose to edit this article, or visit the project page for more information.AIDSWikipedia:WikiProject AIDSTemplate:WikiProject AIDSAIDS articles
Low	This article has been rated as Low-importance on the project's importance scale.

Article title is a neologism

Latest comment: 16 years ago2 comments2 people in discussion

I think it is possible that "Portmanteau inhibitor" is a neologism coined by the researchers cited here. I question whether it is as good a choice as "Portmanteau drug" or "Dual inhibitor". Creating an article with this name may help to "establish" this neologism. Discucss? ManVhv 19:43, 25 July 2007 (UTC)Reply

Given the epidemic-levels of the (mis)use of the word 'portmanteau' in Wikipedia already, any argument for re-naming this article is a good one. But more seriously, is the term 'portmanteau inhibitor' attested in the medical and research literature?Zero sharp (talk) 23:17, 21 April 2008 (UTC)Reply

Sulfasalazine

Latest comment: 12 years ago1 comment1 person in discussion

Would sulfasalazine not fall under the category of a 'portmanteau inhibitor'? It's a combination of antibacterial and anti-inflammatory...and invented many decades before this drug. — Preceding unsigned comment added by 208.80.64.90 (talk) 06:59, 24 May 2012 (UTC)Reply

Add topic